title: Follow-up of tacrolimus breastfed babies.
authors.forename: Aurore
authors.initials: A
authors.lastname: Gouraud
authors.forename: Nathalie
authors.initials: N
authors.lastname: Bernard
authors.forename: Anne
authors.initials: A
authors.lastname: Millaret
authors.forename: Méri
authors.initials: M
authors.lastname: Bruel
authors.forename: Nathalie
authors.initials: N
authors.lastname: Paret
authors.forename: Jacques
authors.initials: J
authors.lastname: Descotes
authors.forename: Thierry
authors.initials: T
authors.lastname: Vial
mesh_terms: D000328:Adult; D001942:Breast Feeding / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D007223:Infant; D007231:Infant, Newborn; D008895:Milk, Human / Q000378:metabolism*; D011247:Pregnancy; D018570:Risk Assessment; D012307:Risk Factors; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus